semaj83/ctmatch_classification huggingface dataset:
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-70.0,  Irritable Bowel Syndrome To be eligible to participate, individuals must meet the Rome III for IBS. That is, they must report that they have had recurrent abdominal pain or discomfort, or a change in stool frequency or form at least three days per month, in the last three months, and that they have been given this diagnosis by a physician. They must also report having pain and discomfort of at least two days per week at time of screening  Individuals who report having post-infectious IBS organic gastrointestinal diseases (e.g., inflammatory bowel disease), immunodeficiency a current psychotic disorder drug or alcohol dependence within the past two years, and those who are unable to communicate in English will be excluded
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Irritable Bowel Syndrome (IBS) Female 18-65 years of age (inclusive) 2. Diagnosed with IBS based on the following (Rome III criteria) Symptom onset at least 6 months prior to diagnosis, and Recurrent abdominal pain or discomfort at least 3 days per month for the past 3 months, and Abdominal discomfort or pain associated with two or more of the following at least 25% of the time improvement with defecation onset associated with a change in frequency of stool/defecation onset associated with a change in form (appearance) of stool 3. Diagnosed with IBS-D, defined as loose/watery stools ≥ 25% and hard/lumpy stools ≤ 25% of defecations  Any structural abnormality of the gastrointestinal (GI) tract (other than esophagitis or gastritis) History of Chron's disease, ulcerative colitis, diabetes mellitus, lactose malabsorption, malabsorption syndromes, celiac sprue, or any upper GI symptoms that may impact the assessment of IBS symptoms
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 0.083-19.0,  Sepsis Critical Illness Children age 1 month-19 years 2. Diagnosis of severe sepsis diagnosed as clinical sepsis syndrome (requires two of the following criteria) Source of infection Fever or Hypothermia Leukocytosis or Leucopenia Poor organ perfusion (such as delayed capillary refill or decreased urine output or hypotension) Bacteremic sepsis demonstrated by positive blood culture 3. Weight greater or equal to 4.0 kg 4. Need for enteral nutrition by a nasogastric/nasoduodenal tube 5. Presence of central and/or arterial venous access as per clinical indication  Patients with metabolic diseases (i.e. Insulin dependent diabetes mellitus, urea cycle disorders, cystinuria, etc.) 2. Pregnancy 3. Primary liver failure 4. Primary renal failure 5. Patients unable to tolerate enteral feedings 6. Weight less than 4.0 kg
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 0.083-19.0,  Sepsis Critical Illness Age 1 month-19 years 2. Diagnosis of severe sepsis diagnosed as clinical sepsis syndrome (requires two of the following criteria) Source of infection Fever or Hypothermia Leukocytosis or Leucopenia Poor organ perfusion (such as delayed capillary refill or decreased urine output or hypotension) Bacteremic sepsis demonstrated by positive blood culture 3. Weight greater or equal to 4 kg 4. Need for parenteral nutrition 5. Presence of central and/or arterial venous access as per clinical indication  Patients with metabolic diseases (i.e. Insulin dependent diabetes mellitus, urea cycle disorders, cystinuria, etc.) 2. Pregnancy 3. Primary liver failure 4. Primary renal failure 5. Patients on enteral feedings greater than 20% of daily requirement 6. Weight less than 4.0 kg
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Abdominal Pain Only patients referred to Pain Clinic for a trigger point injection Non-cancer pain greater than 3 months duration Unilateral abdominal pain Positive Carnett's sign (A test in which acute abdominal pain remains unchanged or increases when the muscles of the abdominal wall are tensed.) An identifiable abdominal trigger point  History of chronic psychotic disorder History of dementing illness Active abdominal visceral disease as a known contributor of the pain Abdominal surgery in the past 6 months More than one trigger point Abdominal wall hernias BMI>40
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-90.0,  Renal Failure The patient requires CRRT as treatment for renal failure, as decided by the attending physician The patient fulfils at least one of the following clinical for initiating CRRT: 1. According to the RIFLE (11) patients satisfying the "injury" (increase creatinine by 2 fold or urine output<0.5ml/kg/hr for 12hr) will be considered for CRRT 2. Hyperkalemia ([K+] > 6.5 mmol/L). 3. Severe acidemia (pH < 7.2). 4. Urea > 25 mmol/liter. 5. Clinically significant organ oedema in the setting of ARF
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Clostridium Difficile Infection Age greater than 18 yrs and less than 75 years Undergoing a clinically indicated colonoscopy  Known, active or recurrent colonic disease including: Clostridium difficile infection, inflammatory bowel disease, microscopic colitis, colon resection for any reason, ischemic colitis, recurrent diverticulitis, colon cancer. Note: Diverticulosis without recurrent diverticulitis, colonic adenomatous or hyperplastic polyps or colonic arteriovenous malformations will not constitute an Diarrhea (an average of more than 3 bowel movements per day at baseline) Constipation (an average of fewer than 2 bowel movements per week at baseline) Use of systemic steroid or systemic immunosuppressive medication Severe renal impairment Relative contraindication to colon biopsy including a bleeding diathesis or anti-coagulant use. Note: nonsteroidal antiinflammatory drug or asprin use will not constitute a contra-indication
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Clostridium Difficile Clostridium Difficile Infection recurrent or refractory CDI previous antimicrobial therapy includes at least on course of vancomycin 4x125 (or higher doses) for at least 7d CDI, defined as: 3 or more loose bowel movements/d AND (presence of C.diff. toxin in stools or toxin producing C. diff. strain) OR (endoscopic or histologic evidence of pseudomembraneous colitis)  no informed consent no ability to provide informed consent immune suppression (continuous immune-suppressive drugs; steroids: prednisolone-equivalent > 20 mg for 14d or longer) lack of appropriate donor pregnancy
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Clostridium Difficile Both genders are eligible for study 2. Age 18 years and older 3. Able to provide written, informed consent 4. Confirmed diagnosis of severe CDAD as defined above  (If any of the following apply, the subject MUST NOT enter the study): 1. Pregnant or lactating women 2. Need for prolonged antibiotics for other cause 3. Other known etiology for diarrhea, or clinical infection with other known enteric pathogens 4. Active, chronic conditions such as: Inflammatory bowel disease, Crohn's disease, Short bowel syndrome, Ulcerative or ischemic colitis 5. Laxatives or motility-altering drugs within 12 hours of enrolment 6. Clinically unstable. Hemodynamic instability defined as hypotension (mean arterial pressure < 60) not responsive to fluids. 7. Any condition that, in the opinion of the investigator, would preclude safe participation in the trial or compromise the quality of the data obtained. 8. Immune suppression, HIV, hematological or solid malignancy (chemotherapy in the past 3 months). 9. Prior colon surgery
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 20.0-999.0,  Abdominal Pain Care Resident physicians will be included if they provide care to adult patients in the Icahn School of Medicine at Mount Sinai's ED. Patients will be enrolled for survey and/or medical record review if All adult (≥20 years) patients seen in the Icahn School of Medicine at Mount Sinai's ED with severe pain (≥10 on a verbal pain scale of 0-10, 0=none, 10=severe) and chief complaints of abdominal pain will be eligible for retrospective and/or medical record review and prospective survey at ED discharge
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 0.083-4.0,  Diarrhea Children aged 1-48 mo admitted to the hospital for reasons other than diarrhea Signed informed consent  Acute gastroenteritis within 3 days before admission Symptoms other than diarrhea suggesting gastroenteritis Use of probiotics within 7 days before admission Immunodeficiency disorders Breastfeeding >50% Underlying gastrointestinal tract disorder Malnutrition (weight/high <3pc)
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Diarrhoea Age 18 to 65 years Good general health Acute diarrhoea episode defined as at least three watery stools per 24 hours over a period of 48 hours or less Acute diarrhoea of presumed infectious origin Patients with usually normal bowel movements (defecations) before onset of diarrhoea, that is, at least three normal stools per week and three or less normal stools per day Negative pregnancy test (ß HCG-test) for women with child bearing potential Written informed consent is a prerequisite for subject enrollment  Known sensitivity to the ingredients of the device Fever >38,5◦C Blood or pus in stools Dehydration requiring intravenous rehydration History of chronic diarrhoea (three or more loose or watery stools per day for at least 12 weeks, consecutive or not, in the preceding 12 months) Use of antidiarrhoeal agents over the month prior to baseline Diarrhoea possibly induced by antibiotics, laxative agents, thyroid hormones, or colchicine Irritable bowel syndrome Any other acute or chronic disease that could interfere with the evaluation of study device Females who are pregnant or lactating
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 15.0-60.0,  Visceral Leishmaniasis Patients with clinical signs and symptoms of primary VL (fever for at least 2 weeks, splenomegaly) and diagnosis confirmed by visualization of parasites in tissue samples (lymph node, bone marrow) on microscopy Patients aged between 15 and 60 years (inclusive) who are able to comply with the protocol Patients for whom written informed consent has been signed by the patients themselves (if aged 18 years and over) or by parents(s) or legal guardian for patients under 18 years of age together with the patients assent HIV negative status  Patients who have previously been diagnosed with VL and received anti-leishmanial treatment (ie relapse) Patients with BMI <16 kg/m2 Patients with contra-indication (known hypersensitivity) to other imidazoles (e.g. ketaconazole) Patients suffering from a concomitant severe underlying disease (cardiac, renal, hepatic) including hepatitis B, para kala-azar dermal leishmaniasis and tuberculosis Patient with clinically significant ECG findings or QTcF≥ 450 msec in 2 successive ECGs Major surgical intervention 4 weeks prior to enrollment Patients who are pregnant or lactating Female patients of child bearing age who do not agree to use an acceptable method of contraception Patients with haemoglobin < 5g/dl Patients with platelets < 40,000/mm³
Patient description: A 34 year old man comes to the clinic complaining of dizziness and severe diarrhea since yesterday. He has returned from an international trip few days ago and was living in a camp in Sudan for a month. He developed abdominal pain followed by bloating and nausea as well as loose bowel movements. Soon he was having profuse watery diarrhea without odor. The stool is watery and white but the patient has no fever. Blood pressure is 95/62 lying down and drops to 75/40 standing. The skin turgor has reduced. HR is 110 and he looks ill with dry mucosa. V. cholerae was seen in dark-field microscopy of a fresh stool specimen. The lab study is as bellow: Sodium 137 meq/L Potassium 2 meq/L Chloride 94meq/L CO2 15 meq/L Fecal leukocytes None seen Fecal occult blood Negative

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Clostridium Difficile Infection Signed Informed Consent Male or female ≥ 18 years of age. Females of childbearing potential must agree to use an adequate and reliable method of contraception Subject with a diagnosis of mild-moderate or severe CDAD (first occurrence or first recurrence within 3 months) with: Diarrhea: a change in bowel habits with > 3 liquid or unformed bowel movements (UBM) within 24 hours prior to randomization, AND Positive C. difficile toxin test on a stool sample produced within 72 hours prior to randomization  More than one previous episode of CDAD in the 3-month period prior to randomization Evidence of life-threatening or fulminant CDAD Likelihood of death within 72 hours from any cause History of inflammatory colitides, chronic abdominal pain, or chronic diarrhea Antimicrobial treatment active against CDAD administered for > 24 hours except for metronidazole treatment failures (MTF) Known hypersensitivity or contraindication to study drugs, oxazolidinones, or quinolones Unable or unwilling to comply with all protocol requirements Any circumstances or conditions, which, in the opinion of the investigator, may affect full participation in the study or compliance with the protocol